Skip to main content
OpenTrials
Completed

NCT Number: NCT01777022

Promoting Awareness Fetal Movements to Reduce Fetal Mortality Stillbirth, a Stepped Wedge Cluster Randomised Trial.

Rates of stillbirth in Scotland are among the highest in resource rich countries. The majority of stillbirths occur in normally formed infants, with (retrospective) evidence of placental insufficiency being the commonest clinical finding. Maternal perception of decreased fetal movements appears to be an early biomarker both of placental insufficiency and subsequent stillbirth.

The study proposed here will test the hypothesis that rates of stillbirth will be reduced by introduction of a package of care consisting of strategies for increasing pregnant women's awareness of the need for prompt reporting of decreased fetal movements, followed by a management plan for identification of placental insufficiency with timely delivery in confirmed cases. The odds of stillbirth fell by 30% after the introduction of a similar package of care in Norway but the efficacy of this intervention (and possible adverse effects and implications for service delivery) have not been tested in a randomized trial.

The investigators plan a stepped wedge cluster design trial, in which hospitals in Scotland and Ireland will be randomized to the timing of introduction of the care package. Outcomes (including the primary outcome of stillbirth) will be derived from Scotland and Ireland's detailed routinely collected maternity data, allowing the investigators to robustly test the hypothesis. A nested qualitative study will examine the acceptability of the intervention to patients and health care providers and identify process issues (barriers to implementation).

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

National Maternity Hospital, Dublin, Ireland

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The study will include all women delivering at one of the maternity units involved in for the duration of the study.

Exclusion criteria

  • Women delivering in the "washout" period in each unit.

Treatment and study plan

A package of interventions

Other

A package of interventions consisting of strategies for increasing pregnant women's awareness of the need to report early when they perceive a reduction in fetal movements, followed with a management plan for identification and delivery of the "at risk" fetus in such women, will reduce rates of stillbirth

Primary outcomes

  1. Rates of stillbirth

    Time frame: 36 months

Secondary outcomes

  1. Rates of caesarean section

    Time frame: 36 months

  2. Rates of induction of labour

    Time frame: 36 Months

  3. Rates of admission to the neonatal intensive care unit

    Time frame: 36 Months

  4. Proportion of women with fetal growth restriction

    Time frame: 36 Months

Other outcomes

  1. Acceptability of package of care to pregnant women and their health care providers

    Time frame: 36 Months

Sponsors and collaborators

Lead sponsor

University of Edinburgh

Other

Collaborators

  • NHS Lothian

Registry information

Official study title

Promoting Awareness Fetal Movements and Focussing Interventions Reduce Fetal Mortality Stillbirth, a Stepped Wedge Cluster Randomised Trial.

Acronym: AFFIRM

Important dates

Study start
2014
Primary completion
2016
Study completion
2017
First posted
Jan 28, 2013
Registry last updated
Feb 8, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.